Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Mazin Faisal Al-Jadiry is active.

Publication


Featured researches published by Mazin Faisal Al-Jadiry.


Pediatric Blood & Cancer | 2011

Treatment of children with B‐cell non‐Hodgkin lymphoma in a low‐income country

Maria Luisa Moleti; Salma Abbas Al-Hadad; Mazin Faisal Al-Jadiry; Amir Fadhil Al-Darraji; Raghad Majid Al-Saeed; Annalisa De Vellis; Alfonso Piciocchi; Stefania Uccini; Robin Foà; Anna Maria Testi

An adapted LMB 96 derived protocol for B‐cell non‐Hodgkin lymphoma (NHL) was implemented at the pediatric oncology unit of the Children Welfare Teaching Hospital in Baghdad (Iraq) from 2000 to present. The purpose was to evaluate the feasibility and efficacy of this intensive therapeutic regimen in a limited resource country.


The New England Journal of Medicine | 2008

Shortage of chemotherapeutic agents in Iraq and outcome of childhood acute lymphocytic leukemia, 1990-2002.

Haydar Frangoul; Mazin Faisal Al-Jadiry; Yu Shyr; Fei Ye; Bashar Shakhtour; Salma Abbas Al-Hadad

These authors determined the effect of the shortage of chemotherapeutic agents on the outcome of acute lymphoblastic leukemia in Iraqi children during the period of UN sanctions (1990–2002). Many of the children received less than 50% of the prescribed chemotherapy, which was associated with a significantly worse outcome.


Journal of Palliative Medicine | 2015

Evaluating Palliative Care Needs in Middle Eastern Countries

Michael Silbermann; Regina Fink; Sung-Joon Min; Mary P Mancuso; Jeannine M. Brant; Ramzi Hajjar; Nesreen Al-Alfi; Lea Baider; Ibrahim Turker; Karima Elshamy; Ibtisam Ghrayeb; Mazin Faisal Al-Jadiry; Khaled Khader; Sultan Kav; Haris Charalambous; Ruchan Uslu; Rejin Kebudi; Gil Bar-Sela; Nilgün Kuruku; Kamer Mutafoglu; Gulsin Ozalp-Senel; Amitai Oberman; Livia Kislev; Mohammad Khleif; Neophyta Keoppi; Sophia Nestoros; Rasha Fahmi Abdalla; Maryam Rassouli; Amira Morag; Ron Sabar

BACKGROUND Cancer incidence in Middle Eastern countries, most categorized as low- and middle-income, is predicted to double in the next 10 years, greater than in any other part of the world. While progress has been made in cancer diagnosis/treatment, much remains to be done to improve palliative care for the majority of patients with cancer who present with advanced disease. OBJECTIVE To determine knowledge, beliefs, barriers, and resources regarding palliative care services in Middle Eastern countries and use findings to inform future educational and training activities. DESIGN Descriptive survey. SETTING/SUBJECTS Fifteen Middle Eastern countries; convenience sample of 776 nurses (44.3%), physicians (38.3%) and psychosocial, academic, and other health care professionals (17.4%) employed in varied settings. MEASUREMENTS Palliative care needs assessment. RESULTS Improved pain management services are key facilitators. Top barriers include lack of designated palliative care beds/services, community awareness, staff training, access to hospice services, and personnel/time. The nonexistence of functioning home-based and hospice services leaves families/providers unable to honor patient wishes. Respondents were least satisfied with discussions around advance directives and wish to learn more about palliative care focusing on communication techniques. Populations requiring special consideration comprise: patients with ethnic diversity, language barriers, and low literacy; pediatric and young adults; and the elderly. CONCLUSIONS The majority of Middle Eastern patients with cancer are treated in outlying regions; the community is pivotal and must be incorporated into future plans for developing palliative care services. Promoting palliative care education and certification for physicians and nurses is crucial; home-based and hospice services must be sustained.


Journal of Pediatric Hematology Oncology | 2011

Reality of pediatric cancer in Iraq.

Salma Al-Hadad; Mazin Faisal Al-Jadiry; Amir Fadhil Al-Darraji; Raghad Majid Al-Saeed; Safaa Faraj Al-Badr; Hasanein Habeeb Ghali

This brief report displays comprehensive details of health services provided by Childrens Welfare Teaching Hospital, medical city, Baghdad. In 2010; 366 children with newly diagnosed cancer were admitted for treatment, two thirds were leukemia and lymphoma cases followed by other solid tumors except brain tumors. With this large number of patients; there are shortcomings in provision of health services in many aspects including professional manpower, infrastructure, diagnostic and therapeutic facilities, supportive and palliative care. The previous wars and sanction and the current instability of the country added to the socioeconomic difficulties of the families jeopardizing the appropriate therapy and ultimately the poor treatment outcome. Since 2003 an international collaboration had a major contribution in many aspects like provision of drugs and medical supplies, attendance of scientific workshops, and updating doctors knowledge and experience through telemedicine programs which resulted in decreasing the induction mortality in acute lymphoblastic leukemia from 24% in the year 2007% to 10% in 2010 after introduction of pre-phase steroids and in acute promyelocytic leukemia from 95% to 5% after introduction of all trans-retinoic acid. A collaborative work with Rome University resulted in changing diagnosis of 20% of pathological samples sent there for reevaluation. Iraqi pediatric oncologists still need real attempts to improve infrastructure and human resources in addition to twinning programs with internationally recognized cancer centers to face these management challenges.


Pediatric Blood & Cancer | 2012

Genetic evaluation of childhood acute lymphoblastic leukemia in Iraq using FTA cards

Lika'a Fasih Y. Al-Kzayer; Kazuo Sakashita; Kazuyuki Matsuda; Salma Abbas Al-Hadad; Mazin Faisal Al-Jadiry; Wisam Majeed Abed; Jaafar M.H. Abdulkadhim; Tariq Abadi Al-Shujairi; Janan Ghalib Hasan; Hussam M.Salih Al-Abdullah; Mouroge H. Al‐Ani; Paiman Ali I. Saber; Toshi Inoshita; Minoru Kamata; Kenichi Koike

Genetic examination of childhood leukemia has not been available in Iraq. We here report the frequency of TEL‐AML1, E2A‐PBX1, MLL‐AF4, and BCR‐ABL chimeric transcripts in 264 Iraqi children newly diagnosed with acute lymphoblastic leukemia (ALL), using FTA cards impregnated with bone marrow aspirate or whole blood.


Journal of Global Oncology | 2016

Middle Eastern Conflicts: Implications for Refugee Health in the European Union and Middle Eastern Host Countries

Michael Silbermann; Michel Daher; Rejin Kebudi; Omar Nimri; Mazin Faisal Al-Jadiry; Lea Baider

Until very recently, health care in conflict settings was based on a model developed in the second half of the twentieth century. Things have changed, and present civil wars, such as those that are currently taking place in the Middle East, do not address the complexity of the ongoing armed conflicts in countries such as Syria, Iraq, and Afghanistan. These conflicts have caused a significant increase in the number of refugees in the region, as well as in Europe. Hundreds of thousands of refugees succeed in settling in mid- and north-European countries, and their health issues are becoming of great importance. Refugees in Europe in the twenty-first century do not suffer so much from infectious diseases but more from noninfectious chronic diseases such as diabetes, cardiac disease, and cancer. These facts profoundly alter the demographics and disease burden of hostility-derived migrants. Thus, host European countries face situations they have never faced before. Hence, new approaches and strategies are urgently needed to cope with this new situation. The efforts to absorb refugees of different traditions and cultural backgrounds often cause increasing ethnic and religious tensions, which frequently escort the emergence of social violence. To date, little attention has been paid to the overall load of distress being experienced, especially among the first-generation refugees. The current ongoing hostilities in the Middle East induce a long-term health impact on people expelled from their homes, communities, traditions, and cultural environment. The realization of collective suffering forces communities and governmental health agencies to develop new programs that include social determinants to overcome the severe cultural gaps of the newcomers in their new European host countries.


Pediatric Blood & Cancer | 2014

Frequent coexistence of RAS mutations in RUNX1-mutated acute myeloid leukemia in Arab Asian children.

Lika'a Fasih Y. Al-Kzayer; Kazuo Sakashita; Mazin Faisal Al-Jadiry; Salma Abbas Al-Hadad; Le T.N. Uyen; Tingting Liu; Kazuyuki Matsuda; Jaafar M.H. Abdulkadhim; Tariq Abadi Al-Shujairi; Zead Ismael I.K. Matti; Janan Ghalib Hasan; Hussam M.Salih Al-Abdullah; Toshi Inoshita; Minoru Kamata; Maher A. Sughayer; Faris Madanat; Kenichi Koike

RUNX1 mutation plays an important role in adult leukemic transformation. However, its contribution to the development of childhood leukemia remains unclear. In the present study, we analyzed point mutations of RUNX1 gene in children and adolescents with acute myeloid leukemia (AML) from Iraq and Jordan.


Pediatric Blood & Cancer | 2011

Gastric perforation as a primary manifestation of lymphomatoid granulomatosis

Stefania Uccini; Anna Maria Testi; Safaa A. F. Al-Badri; Amir Fadhil Al-Darraji; Salma Abbas Al-Hadad; Mazin Faisal Al-Jadiry

To the Editor: Lymphomatoid granulomatosis (LYG) is a rare necrotizing angiocentric and angiodestructive Epstein–Barr virus (EBV)-associated B-cell lymphoproliferative disorder composed predominantly of reactive T cells and fewer scattered neoplastic EBV-positive B cells [1,2]. LYG involves characteristically extranodal sites such as lungs, skin, and central nervous system, is more common in adults between the fourth and sixth decades, and is frequently associated to immunodeficiency disorders [3,4]. Its occurrence in children is quite rare [5,6] and a primary gastrointestinal manifestation of LYG is extremely infrequent, even in adult patients [7].


Pediatric Blood & Cancer | 2015

Analysis of KRAS and NRAS Gene Mutations in Arab Asian Children With Acute Leukemia: High Frequency of RAS Mutations in Acute Lymphoblastic Leukemia

Lika'a Fasih Y. Al-Kzayer; Kazuo Sakashita; Mazin Faisal Al-Jadiry; Salma Abbas Al-Hadad; Hasanein Habeeb Ghali; Le T.N. Uyen; Tingting Liu; Kazuyuki Matsuda; Jaafar M.H. Abdulkadhim; Tariq Abadi Al-Shujairi; Zead Ismael I.K. Matti; Maher A. Sughayer; Rawad Rihani; Faris Madanat; Toshi Inoshita; Minoru Kamata; Kenichi Koike

KRAS and NRAS gene mutations are frequently observed in childhood leukemia. The objective of this study was to determine the frequency of RAS mutations and the association between RAS mutations and other genetic aberrations in Arab Asian children with acute lymphoblastic leukemia (ALL) or acute myeloid leukemia (AML).


Pediatric Blood & Cancer | 2018

Burkitt lymphoma in Iraqi children: A distinctive form of sporadic disease with high incidence of EBV+ cases and more frequent expression of MUM1/IRF4 protein in cases with head and neck presentation.

Stefania Uccini; Mazin Faisal Al-Jadiry; Claudia Cippitelli; Caterina Talerico; Stefania Scarpino; Amir Fadhil Al-Darraji; Safaa A. F. Al-Badri; Adel R. Alsaadawi; Salma Abbas Al-Hadad; Luigi Ruco

Epstein‐Barr virus (EBV)‐related lymphoproliferative disorders are relatively common in Iraqi children. Burkitt lymphoma (BL) accounted for 40% of lymphoma cases. The mean age of 125 BL cases was 5.9 ± 3.1 years, and the male‐to‐female ratio was 3.6:1. Clinical presentation was abdominal in 66% and head and neck in 34%. Bone marrow involvement was higher (P < 0.001) in children with head and neck disease. Tumor cells had MYC translocation (96%) and were CD20+/CD10+/MYC+/BCL2−. MUM1/IRF4 staining was expressed by a fraction of tumor cells in 19 of 125 cases (15%) and was more frequent (P < 0.007) in head and neck disease (12/42; 29%). EBV‐encoded RNA was positive in 100 of 125 (80%) BL cases.

Collaboration


Dive into the Mazin Faisal Al-Jadiry's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Anna Maria Testi

Sapienza University of Rome

View shared research outputs
Top Co-Authors

Avatar

Stefania Uccini

Sapienza University of Rome

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge